Erdogan-Trinkaus Ipek Insider Trading -- Recent SEC Form 4 Transactions
Erdogan-Trinkaus Ipek (CIK 2047026) reported 4 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-11-12). Recent activity: Buy ETON (3,500 shares), Sell ETON (2,340 shares), Sell ETON (1,160 shares), Sell ETON (85 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-11-12 | Eton Pharmaceuticals, Inc. (ETON) | Chief Commercial Officer | Buy | 3,500 | $54,145 |
| 2026-11-12 | Eton Pharmaceuticals, Inc. (ETON) | Chief Commercial Officer | Sell | 2,340 | $157,198 |
| 2026-11-12 | Eton Pharmaceuticals, Inc. (ETON) | Chief Commercial Officer | Sell | 1,160 | $78,739 |
| 2025-12-12 | Eton Pharmaceuticals, Inc. (ETON) | Chief Commercial Officer | Sell | 85 | $1,436 |
Source: SEC Form 4 filings · as of 2026-11-12